The deferasirox market is estimated at USD 38.57 million in 2026, is projected to reach USD 62.06 million by 2036 and is forecast to register a 4.9% CAGR between 2026 and 2036. In 2026, transfusional iron overload holds 72.4% of application sales and powder represents 64.8% within the form segment.